This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

B. Nakamura, M.D.
Osaka, Japan.

Arch Ophthal. 1933;10(3):423.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor:—The following inquiries have been received pertaining to my paper, entitled, "Specific Treatment of Ophthalmic Tuberculosis with a New Tuberculosis Antigen `A O,' " in the August issue of the ARCHIVES, page 161. As ophthalmologists in general may be interested in them, I am sending the answers for publication:

1. Where is A O to be obtained? It can be obtained at Arimakenkiujo Ebie Nishinariku, Osaka, Japan.
   
2. When you are using a single optimal dose, do you always give it at four day intervals, and for how long a period?
   
3. For fifteen years I have been using only the optimal dose, but during the past year I have used A O, no. 1, 1 cc. for the optimal dose, for adults, every eight days.
   
4. What method have you found the best for diagnosis, the subcutaneous reaction to tuberculin or the Mantoux intradermal test? Patients are
   

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?